Aspirin, Heparin and Miscarriage

Low Dose Aspirin and Low-molecular-weight Heparin in the Treatment of Pregnant Libyan Women With Recurrent Miscarriage

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01917799

Enrollment

150

Registered

2013-08-07

Start date

2009-01-31

Completion date

2013-12-31

Last updated

2013-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Miscarriage, Pregnancy

Keywords

Aspirin, Heparin, pregnancy, miscarriage

Brief summary

Efficacy of low dose aspirin (LDA) versus LDA plus low-molecular-weight-heparin (LMWH) in patients with a history of recurrent miscarriages.

Interventions

DRUGAspirin

75mg tab of LDA once daily for 7 months

DRUGHeparin

0.4 mL/day of the Enoxaparin

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

15 Years to 48 Years

Healthy volunteers

Inclusion criteria

* Pregnant women * History of 2 or more of miscarriage

Exclusion criteria

* Twins

Design outcomes

Primary

Measure	Time frame	Description
Number of miscarriages	3 months	To compare number of miscarriages between the two groups

Countries

Libya

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026